cluster
regularli
interspac
short
palindrom
repeat
crispr
associ
ca
system
first
discov
immun
respons
bacteriophag
infect
invad
plasmid
prokaryot
bacteria
archaea
crisprca
immun
system
involv
ca
bind
rna
transcrib
palindrom
repeat
dna
cleav
dna
pair
rna
transcript
short
stretch
dna
acquir
extra
chromosom
element
specif
use
type
ii
crisprca
system
transcript
palindrom
repeat
dna
call
transactiv
cripsr
rna
tracr
rna
spacer
transcript
name
cripsr
rna
crrna
tracr
rna
crrna
link
togeth
form
singl
guid
rna
sgrna
direct
induc
doubl
strand
dna
break
protospac
adjac
motif
pam
region
cleavag
stimul
nonhomolog
end
join
nhej
homologydirect
repair
hdr
mediat
genom
edit
thu
caus
insert
delet
indel
genom
cell
initi
confirm
systemmedi
genom
edit
eukaryot
mammalian
cell
seri
mutant
analogu
multi
cirsprca
deliveri
vector
lentivir
lv
adenovir
av
well
adeno
associ
viral
aav
broaden
applic
variou
research
field
crystal
structur
studi
bound
sgrna
target
dna
reveal
protein
harbor
two
import
nucleas
domain
ruvc
histidineasparaginehistidin
hnh
essenti
cleavag
complementari
noncomplementari
strand
target
dna
mutat
ruvc
hnh
domain
allow
convert
dna
nickas
cleav
singl
strand
break
induc
specif
nonhomolog
end
join
nhej
homolog
recombin
hr
inact
bind
sgrna
target
dna
without
cleavag
versatil
tool
appli
regul
gene
express
qi
et
al
name
crispr
interfer
crispri
technolog
effici
inhibit
express
target
gene
escherichia
coli
well
mammalian
cell
transcript
block
elong
ribonucl
acid
polymeras
rnap
sgrna
complex
howev
crispri
achiev
fold
decreas
gene
express
human
cell
improv
efficaci
crispri
fuse
repress
chromatin
modifi
domain
associ
box
krab
protein
artifici
recruit
chromatinmodifi
complex
silenc
transcript
sgrna
target
gene
comparison
crispri
inhibit
gene
express
combin
four
copi
transcript
activ
viru
protein
transcript
factor
encod
gene
herp
simplex
singl
copi
activ
domain
ad
transactiv
gene
transcript
cell
addit
singl
multipl
grna
target
gene
promot
direct
activ
transcript
endogen
human
gene
exploit
found
grna
target
multipl
loci
promot
synergist
effect
activ
gene
express
thereaft
zhang
group
describ
structur
guid
optim
complex
induc
effici
transcript
activ
ten
endogen
gene
one
time
system
contain
previous
report
fusion
protein
engin
sgrna
contain
substitut
tetraloop
stem
loop
domain
two
minim
hairpin
aptam
select
interact
dimer
bacteriophag
bacteri
viru
coat
protein
fuse
transactiv
subunit
activ
domain
human
heatshock
factor
transcript
activ
recruit
distinct
subset
transcript
factor
swisnf
complex
origin
defin
yeast
protein
complex
import
cellular
respons
matingtyp
switch
swi
sucros
ferment
snf
recruit
atfcreb
wherea
improv
transcript
complex
activ
tripl
combin
compris
effect
synergist
activ
mediat
sam
system
addit
sgrna
target
bp
upstream
transcript
start
site
potenti
activ
efficaci
addit
sam
system
tanenbaum
et
al
develop
anoth
system
significantli
improv
express
endogen
gene
crispra
system
synthet
transcript
activ
fuse
green
fluoresc
protein
gfp
singl
chain
variabl
fragment
scfv
antibodi
bind
specif
peptid
deriv
gener
control
protein
fuse
peptid
tag
suntag
recruit
copi
gfp
lead
spatial
recruit
multipl
domain
grnacomplementari
target
site
therefor
sgrna
constitut
system
provid
versatil
toolset
gene
activ
sinc
fulllength
kb
larg
size
limit
usag
basic
research
therapeut
applic
adenovir
lentivir
vector
deliveri
tool
howev
lentivir
vector
integr
host
genom
potenti
risk
factor
induct
carcinogenesi
wherea
adenovir
vector
strong
immunogen
effect
human
cell
order
identifi
versatil
genomeedit
platform
smaller
cargo
size
ran
et
al
found
staphylococcu
aureu
kb
shorter
compar
packag
highli
versatil
adenoassoci
viru
aav
deliveri
vector
broadli
use
clinic
research
due
broad
rang
serotyp
specif
reduc
oncogen
risk
hostgenom
integr
low
immunogen
potenti
howev
drawback
concern
readministr
aav
vector
immunogen
consequ
reduc
redeliveri
aav
vector
asid
nngrrt
pam
target
site
wild
type
kleinstiv
et
al
gener
kkh
variant
harbor
broad
target
recognit
site
nna
ct
rrt
pam
tremend
promis
biomed
research
genom
edit
success
appli
plant
zebra
fish
mous
model
furthermor
crystal
structur
complex
sgrna
target
dna
report
provid
structur
inform
base
design
crispri
crispra
use
expand
genom
edit
choic
assign
class
type
v
crispr
system
zhang
group
first
experiment
confirm
applic
genom
edit
tool
mammalian
cell
distinct
singl
rnaguid
endonucleas
without
tracrrna
recogn
pam
protospac
characterist
enabl
cleavag
atrich
genom
singl
crrna
nucleotid
long
spacer
repeat
test
protein
variou
bacteria
two
enzym
acidaminococcu
sp
lachnospiracea
bacterium
found
abil
manipul
genom
human
cell
solv
crystal
structur
five
amino
acid
residu
mutant
develop
target
gene
mammalian
cell
mous
brain
use
aav
cassett
contain
singl
target
array
multiplex
crrna
nuclear
local
signal
nl
fuse
simplic
crrna
design
high
effici
genom
edit
enabl
exert
genet
oper
varieti
organ
includ
cyanobacteria
rice
tobacco
mice
addit
dna
cleavag
francisella
novicida
also
rnase
activ
process
precrrna
matur
crrna
vitro
design
rna
genom
target
dual
dnase
rnase
activ
consid
design
lentivir
vector
express
crrna
nucleas
howev
target
rna
mammalian
cell
report
need
research
f
novicida
encod
gene
predict
compon
crisprca
system
bioinformat
analysi
distinct
typic
crisprca
system
induc
foreign
dna
breakag
degrad
modul
endogen
antibacteri
lipoprotein
blp
express
degrad
mrna
thu
facilit
bacteri
evas
innat
immun
defens
system
increas
virul
tracrrna
scarna
contribut
virul
bacteri
mutant
compon
design
attract
vaccin
strain
pathogen
base
find
use
target
human
positivesens
singlestrand
rna
ssrna
viru
hepat
c
viru
hcv
rna
guid
hcv
rna
genom
degrad
research
provid
direct
evid
versatil
rnaedit
system
effect
function
antivir
defens
toolset
eukaryot
cell
crisprca
system
gener
three
step
spacer
format
crrna
gener
genet
interfer
accord
architectur
interfer
modul
crisprca
system
divid
group
class
contain
type
iii
iv
util
crrna
bind
multisubunit
effector
complex
compris
variou
ca
protein
class
includ
type
ii
v
vi
use
crrna
associ
singl
unit
ca
protein
studi
class
candid
accord
effector
modul
singl
unit
crrna
belong
class
type
v
crisprca
system
harbor
ruvclik
endonucleas
domain
break
dna
guid
tracrrna
contain
two
predict
higher
eukaryot
prokaryot
nucleotidebind
hepn
rnase
domain
target
rna
furthermor
bacteria
leptotrichia
buccali
listeria
seeligeri
leptotrichia
shahii
experiment
confirm
rnaguid
rnatarget
crispr
effector
induc
singl
strand
rna
ssrna
cleavag
vitro
prokaryot
addit
detail
molecular
principl
crispr
target
demonstr
two
crystal
structur
research
group
use
alicyclobacillu
acidoterrestri
howev
mechan
engin
edit
eukaryot
cell
challeng
explor
futur
belong
class
type
vi
rnaguid
rna
nucleas
three
protein
identifi
leptotrichia
wadei
engin
target
endogen
transcript
human
cell
plant
moreov
monomer
superfold
gfp
msfgfp
fuse
stabil
specif
develop
programm
track
transcript
live
cell
ortholog
prevotella
sp
ctermin
fuse
nuclear
export
signal
ne
domain
hiv
rev
gene
effici
rna
interfer
mammalian
cell
mutat
conserv
catalyt
residu
hepn
domain
lack
nucleas
activ
fuse
deaminas
domain
adar
adardd
natur
deamin
adenosin
insosin
dsrna
engin
modifi
rna
rna
edit
programm
g
replac
repair
furthermor
enhanc
specif
util
ration
mutagenesi
strategi
mutant
fuse
show
precis
effici
highli
specif
rna
target
term
offer
altern
rna
edit
toolset
modifi
residu
protein
thu
alter
function
regul
diseas
autoimmun
disord
includ
psoriasi
immunoglobulin
defici
type
diabet
system
lupu
erythematosu
howev
temporari
natur
repair
system
restrict
applic
diseas
caus
temporari
chang
cell
state
high
offtarget
efficaci
need
attent
design
target
guid
rna
virushost
interact
dynam
persist
process
viru
exploit
host
factor
complet
life
cycl
host
use
immun
defens
system
inhibit
clear
viral
infect
addit
innat
immun
system
adapt
immun
apparatu
host
cell
evolv
express
gener
restrict
factor
block
viru
replic
counteract
virus
use
specif
strategi
escap
immun
surveil
thu
crisprca
system
treat
viru
relat
diseas
conduct
target
viral
nucleic
acid
well
host
factor
includ
posit
neg
regul
shown
figur
first
system
explor
gene
therapi
research
ye
et
al
report
util
combin
piggybac
technolog
mutat
ipsc
without
offtarget
modif
genom
edit
ipsc
differenti
monocytesmacrophag
demonstr
resist
challeng
vitro
wang
et
al
show
tzmbl
cell
human
cell
line
transduc
lentivir
plasmid
express
select
advantag
infect
confer
resist
infect
infecti
molecular
clone
transmittedfound
tf
isol
pthro
pwito
prejo
li
et
al
use
chimer
adenoviru
vector
deliveri
result
effici
silenc
thu
resist
primari
cell
mandal
et
al
util
dual
guid
approach
gener
biallel
delet
primari
human
hematopoiet
stem
progenitor
cell
hspc
cell
modifi
hspc
retain
multilineag
capabl
differenti
effector
cell
lymphoid
cell
myeloid
cell
also
confirm
vivo
differenti
hspc
use
nsg
recipi
xu
et
al
disrupt
human
hspc
use
select
sgrna
target
region
modifi
hspc
differenti
activ
vitro
resist
nodscid
mice
npg
mice
bring
crisprca
mediat
gene
therapi
closer
clinic
treatment
studi
demonstr
broad
applic
target
hematopoiet
cell
base
gene
therapi
howev
asid
primari
receptor
one
coreceptor
tropic
strain
entri
target
cell
cxc
chemokin
receptor
type
anoth
coreceptor
exploit
tropic
strain
consid
anoth
import
target
genom
edit
infect
late
stage
aid
util
altern
coreceptor
enter
new
cell
caus
faster
diseas
progress
order
address
possibl
design
two
sgrna
induc
first
gener
disrupt
primari
human
cell
gener
resist
cell
without
offtarget
effect
thereaft
hultquist
et
al
program
genom
primari
cell
electropor
ribonucleoprotein
sgrna
confer
cell
tropismdepend
hiv
resist
phenotyp
addit
simultan
knockout
use
one
combin
sgrna
assess
primari
cell
show
inhibit
dual
tropic
infect
group
combin
one
sgrna
togeth
two
sgrna
one
vector
induc
disrupt
simultan
primari
cell
genomeedit
cell
select
advantag
orand
infect
vector
nonspecif
cleavag
cytotox
disrupt
show
specif
target
receptor
latent
proviru
integr
genom
jurkat
cell
microglia
cell
monocyt
cell
hela
cell
remov
liao
et
al
report
grna
target
integr
genom
dna
caus
resist
incom
infect
primari
cell
complet
life
cycl
host
factor
essenti
replic
packag
bud
thu
knockout
necessari
auxiliari
gene
anoth
altern
strategi
block
infect
note
loss
gene
may
effect
cellular
function
previou
studi
found
sever
host
depend
factor
len
epitheliumderiv
growth
factor
interact
protein
nucleoporin
cleavag
polyadenyl
specif
factor
subunit
activ
leukocyt
cell
adhes
molecul
alcam
electropor
ribonucleoprotein
rnp
primari
cell
hultquist
et
al
success
knockedout
ledgf
caus
tropismindepend
reduct
infect
recent
studi
use
genomewid
screen
approach
unveil
larg
number
host
factor
may
essenti
replic
thu
provid
potenti
therapeut
target
use
crisprca
system
sinc
newli
identifi
kb
togeth
sgrna
ideal
cassett
deliv
aav
vehicl
gene
therapi
compar
lentiviru
adenoviru
aav
capsid
packag
less
kb
singlestrand
dna
addit
aav
attract
consider
interest
gene
therapi
mani
advantag
low
toxic
lack
pathogen
sustain
gene
express
safe
effici
deliveri
broad
serotyp
tropism
rang
howev
readministr
aav
serotyp
caus
immun
respons
reduc
efficaci
aav
deliveri
aavbas
express
compar
aav
subtyp
vector
achiev
effici
gene
edit
transduc
primari
cell
hematopoiet
cell
design
sgrna
induc
target
cell
line
chose
two
packag
transduc
primari
cell
edit
cell
demonstr
tropic
resist
also
use
success
target
primari
cell
hsc
vitro
edit
cell
show
resist
nsg
mice
paper
submit
besid
manuscript
revis
group
also
show
aavmedi
could
use
excis
integr
genom
cultur
progenitorneur
stem
cell
transgen
mice
latent
cell
line
date
highli
activ
antiretrovir
therapi
haart
global
strategi
treatment
infect
patient
howev
repress
replic
undetect
level
abl
clear
viru
cell
cession
antiretrovir
drug
hiv
rebound
persist
viral
reservoir
form
latent
silent
proviru
although
proviru
bypass
host
immun
system
surveil
new
virus
gener
activ
quiescent
proviru
repress
haart
viru
produc
cell
recogn
clear
host
immun
apparatu
therefor
socal
shock
kill
method
theori
cure
aid
draw
much
attent
erad
hiv
infect
cell
base
find
crispra
util
reactiv
induc
express
quiescent
proviru
shock
would
activ
host
immun
respons
kill
hiv
infect
cell
zhang
et
al
confirm
proofofconcept
therapeut
approach
use
system
sgrna
target
ltr
promot
latent
cell
line
jlat
microgli
cell
line
addit
sheena
et
al
identifi
hotspot
site
sgrna
bind
activ
within
viral
enhanc
sequenc
ltr
promot
furthermor
prajit
et
al
also
report
sam
complex
contain
induc
express
cellbas
model
latenc
target
differ
ltr
region
ji
et
al
use
singl
sgrna
target
ltr
effect
reactiv
latent
proviru
transcript
latent
infect
human
tcell
line
mention
reli
sever
host
protein
fulfil
effici
viru
propag
strategi
use
crisprca
mediat
knock
essenti
cellular
gene
block
replic
hand
human
cell
develop
defens
system
deter
key
step
viru
lifecycl
therebi
restrict
viral
replic
restrict
factor
activ
crispra
function
antihiv
defens
sever
potent
restrict
factor
confirm
effect
inhibit
hiv
replic
tripartit
motif
cytoplasm
protein
interact
incom
retrovir
capsid
ca
block
viru
replic
suscept
cell
line
cellderiv
macrophag
speciesspecif
manner
mutant
show
strong
restrict
infect
tcell
line
martha
et
al
gener
artifici
antihiv
cassett
fuse
apex
pryspri
domain
human
cyclophilin
cypa
mimic
antiretroviru
function
new
world
monkey
genu
aotu
apolipoprotein
b
mrnaedit
enzym
catalyt
polypeptid
apobec
protein
group
polynucleotid
cytidin
deaminas
caus
deamin
cytosin
base
either
rna
dna
thu
convert
cytidin
c
uridin
u
antivir
activ
speciesspecif
counteract
vif
mutat
block
antagon
vif
restor
cytidin
deaminas
activ
viral
rna
interferon
induc
antivir
host
protein
prevent
replic
inhibit
viral
particl
releas
tetherin
counteract
vpu
protein
substitut
singl
amino
acid
tetherin
confer
vpuresist
steril
alpha
motif
hddomain
contain
protein
key
syndrom
relat
gene
whose
function
restrict
factor
inhibit
lentiviru
infect
myeloid
cell
restrict
counteract
vpx
vpxinduc
proteasom
degrad
dgtpdepend
deoxynucleosid
triphosphohydrolas
reduc
intracellular
dntp
level
requir
revers
transcript
therebi
block
infect
rest
tcell
myxoviru
resist
protein
interferon
induc
inhibitor
infect
prevent
capsiddepend
nuclear
import
subvir
complex
late
stage
infect
voit
et
al
found
combin
disrupt
restrict
factor
overexpress
signific
protect
effect
infect
design
target
vector
combin
rev
block
infect
multipl
stage
thu
provid
roadmap
crispr
target
applic
applic
crispra
target
hiv
restrict
factor
one
paper
show
sam
system
singl
sgrna
combin
two
sgrna
activ
endogen
inhibit
infect
convert
dctodu
edit
hiv
genom
howev
activ
host
genet
regul
crispra
need
investig
recent
pair
restrict
factorvir
accessori
protein
recent
discov
also
potenti
target
crispra
hbv
infect
relat
diseas
remain
seriou
threat
human
health
hbv
contain
relax
circular
rc
dna
genom
convert
coval
close
circular
ccc
dna
cellular
enzym
infect
hepatocyt
ccc
dna
transcrib
four
viral
rna
includ
pregenom
rna
pgrna
pre
x
pgrna
serv
templat
revers
transcript
genom
dna
togeth
subgenom
rna
mrna
produc
core
c
polymeras
p
surfac
viral
glycoprotein
hbeag
hepat
b
viru
x
hbx
protein
base
principl
cleavag
hbv
cccdna
ideal
target
gene
edit
sever
studi
util
edit
conserv
open
read
frame
orf
hbv
cccdna
erad
viru
cell
mous
model
howev
report
use
crisprca
system
hbv
infect
primari
cell
kind
crisprca
system
effici
edit
hbv
genom
also
need
investig
comparison
asid
viru
genom
edit
host
factor
also
could
target
prevent
hbv
infect
first
target
consid
identifi
receptor
bile
acid
pump
sodium
taurochol
cotransport
polypeptid
ntcp
inhibit
ntcp
protein
express
prevent
hbv
replic
suggest
knockout
ntcp
crisprca
system
may
strategi
block
hbv
infect
key
host
factor
involv
hbv
replic
also
consid
target
exampl
heat
stress
cognat
essenti
protein
hbv
replic
necessari
cell
surviv
thu
crisprca
edit
may
contribut
inhibit
hbv
replic
heat
shock
protein
known
pivot
compon
sever
signal
pathway
report
necessari
host
factor
hepat
b
viru
replic
hbv
life
cycl
tyrosyldnaphosphodiesteras
identifi
specif
break
tyrosinedna
bond
hbv
dhbv
rcdna
releas
viral
p
protein
help
convers
rcdna
cccdna
thu
knockdown
human
cell
dramat
deceler
convers
rcdna
cccdna
research
also
identifi
put
member
clathrin
adaptor
protein
involv
protein
sort
traffick
bind
l
protein
togeth
pre
domain
perform
crucial
function
mediat
attach
hbv
liver
cell
interferoninduc
antivir
factor
block
releas
divers
envelop
virus
includ
hbv
altogeth
host
factor
could
target
crisprca
system
treat
hbv
relat
diseas
furthermor
hbv
regulatori
incrna
pgrna
well
subgenom
rna
also
consid
target
rna
edit
system
accord
report
although
two
effect
human
papillomaviru
hpv
vaccin
avail
hpv
relat
cervic
cancer
remain
second
common
cancer
women
worldwid
classifi
agestandard
incid
rate
asr
http
wwwwhointimmunizationtopicshpven
hpv
also
induc
type
anogenit
cancer
head
neck
cancer
genit
wart
men
women
dsdna
genom
hpv
may
integr
host
cell
chromosom
make
genom
ideal
target
crisprca
edit
among
identifi
genotyp
hpv
commonli
highrisk
hpv
type
detect
cervic
penil
cancer
frequent
lowrisk
hpv
type
associ
anogenit
wart
laryng
papillomatosi
hpvrelat
tumorigenesi
relat
deregul
express
two
oncogen
protein
hpv
import
malign
transform
mainten
malign
phenotyp
cervic
cancer
hpv
invad
host
cell
express
induc
degrad
tumorsuppress
protein
inactiv
retinoblastoma
rb
protein
thu
block
cell
cycl
therefor
two
viral
oncogen
becom
main
target
combat
hpv
infect
technolog
use
hpvassoci
cancer
kennedi
et
al
design
sgrna
target
orf
integr
human
siha
hela
cervic
carcinoma
cell
line
genom
rnaguid
abl
inactiv
cleav
gene
transform
siha
cell
hela
cell
respect
zhen
et
al
also
use
system
target
lead
enhanc
express
rb
acceler
siha
cell
apoptosi
furthermor
siha
cell
introduc
balbc
nude
mice
reduc
tumor
size
compar
control
mani
host
cell
restrict
factor
limit
transcript
replic
hpv
gammainterferoninduc
protein
ccaatenhanc
bind
protein
beta
epidermodysplasia
verruciformi
ever
apobec
fanconi
anemia
complement
group
et
al
could
activ
crispra
block
hpv
infect
recent
function
studi
also
provid
host
target
hpv
gene
therapi
sirtuin
bromodomaincontain
protein
kruppel
like
factor
origin
recognit
complex
subunit
viru
ebv
belong
gamma
herp
viru
famili
contain
linear
dsdna
ebv
infect
caus
lifelong
persist
infect
adult
peopl
although
ebv
induc
diseas
healthi
carrier
caus
infecti
mononucleosi
strongli
associ
mani
lymphoid
epitheli
malign
posttranspl
lymphoprolif
disord
ptld
gastric
carcinoma
burkitt
lymphoma
hodgkin
lymphoma
nasopharyng
carcinoma
major
ebvassoci
diseas
induc
latenc
system
use
target
herpesvirus
especi
treatment
ebv
wang
et
al
design
seven
guid
rna
target
six
differ
region
ebv
genom
differ
edit
purpos
transfect
burkitt
lymphoma
patientderiv
b
cell
line
target
reduc
episom
ebv
genom
content
infect
cell
lead
dramat
cell
prolifer
arrest
concomit
decreas
viral
load
subsequ
yuan
et
al
design
two
sgrna
target
bp
region
promot
region
bart
bamhi
rightward
transcript
major
viral
transcript
deriv
latent
infect
cell
encod
viral
microrna
mirna
observ
gene
disrupt
nasopharyng
carcinoma
cell
latent
infect
ebv
indic
potenti
treatment
ebv
infect
furthermor
van
diemen
et
al
use
singl
sgrna
target
ebv
nuclear
antigen
origin
replic
region
lentiviru
mediat
burkitt
lymphoma
cell
could
deplet
ebv
genom
wherea
target
two
differ
sgrna
simultan
made
effici
high
recent
screen
use
explor
ebv
transform
b
cell
host
depend
factor
order
find
host
depend
factor
result
ebv
lymphoblastoid
cell
research
conduct
parallel
genomewid
lossoffunct
screen
bl
lymphoblastoid
cell
line
lcl
systemat
approach
identifi
key
mechan
ebv
oncoprotein
activ
pathway
evad
tumor
suppressor
respons
ebvinduc
essenti
myc
induct
bim
suppress
lcl
ebv
superenhancertarget
could
protect
lcl
form
tumor
suppress
asid
ebv
system
also
use
herpesvirus
human
cytomegaloviru
hcmv
genom
edit
therefor
system
promis
technolog
deplet
ebv
vivo
yet
studi
must
conduct
test
feasibl
hcv
positivestrand
rna
genom
consist
region
ncr
orf
one
main
pathogen
caus
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
peopl
infect
hcv
becom
chronic
carrier
hcv
associ
liver
diseas
often
along
hiv
infect
price
et
al
util
target
hcv
genom
ssrna
human
hepatocellular
carcinoma
cell
observ
viru
inhibit
due
blockad
viral
rna
translat
viral
replic
machineri
rather
genom
rna
breakag
inhibit
function
rnai
crispri
imped
mrna
express
sinc
crisprca
system
develop
mammalian
cell
genom
edit
program
screen
host
factor
regul
variou
viru
life
cycl
one
applic
librari
usag
nird
system
identifi
essenti
gene
hcv
ren
et
al
found
three
gene
cluster
differenti
claudin
occludin
ocln
necessari
celltocel
transmiss
cellfre
entri
hcv
infect
altern
librari
design
screen
regulatori
target
incrna
mirna
hcv
life
cycl
outbreak
flavivirus
zikv
denv
nonflavivirus
wnv
ebov
sarscov
merscov
influenza
viru
often
caus
acut
diseas
induc
apprehens
panic
world
effect
drug
altern
therapi
inhibit
spread
acut
viral
infect
hot
topic
research
basic
prerequisit
block
pandem
understand
mechan
virushost
interact
research
spent
much
effort
identifi
essenti
host
factor
rapidli
emerg
pathogen
genomewid
knockout
screen
identifi
gene
essenti
flaviviru
infect
zhang
et
al
confirm
nine
human
gene
contribut
replic
flavivirida
famili
member
includ
wnv
denv
zikv
yellow
fever
viru
japanes
enceph
viru
hcv
import
target
subset
endoplasm
reticulumassoci
signal
peptidas
complex
spc
protein
mediat
cleavag
flaviviru
structur
protein
prm
e
releas
viral
particl
time
pool
crispr
genet
screen
strategi
marceau
et
al
identifi
endoplasmicreticulum
er
associ
multiprotein
complex
involv
denv
zikv
replic
also
found
interact
oligosaccharyltransferas
ost
complex
denv
nonstructur
protein
micro
well
micro
rnadigeorg
syndrom
chromosom
region
import
hcv
replic
addit
savidi
et
al
combin
rnai
approach
verifi
axl
receptor
tyrosin
kinas
axl
rabgef
ndeacetylas
nsulfotransferas
exostosin
glycosyltransferas
endoplasm
reticulum
er
membran
complex
emc
import
denv
zikv
infect
differ
life
cycl
stage
moreov
gootenberg
et
al
develop
detect
platform
name
specif
highsensit
enzymat
report
unlock
sherlock
discrimin
specif
strain
denv
zikv
use
isotherm
amplif
et
al
identifi
seven
endoplasm
reticulumassoci
protein
degrad
erad
pathway
relat
gene
contain
erassoci
degrad
erad
ligas
adaptor
subunit
derlin
eradassoci
ubiquitinprotein
ligas
import
essenti
wnv
replic
heaton
et
al
util
crispra
system
identifi
influenza
viru
restrict
factor
genom
scale
level
found
inhibit
sever
influenza
viru
strain
bind
link
sialic
acid
receptor
abolish
infect
ebola
viru
ebov
diseas
evd
epidem
west
africa
attract
much
attent
world
accord
statist
analysi
ebov
caus
case
death
mainli
guinea
sierra
leon
liberia
ebov
contain
kb
singlestrand
rna
genom
encod
seven
structur
protein
nucleoprotein
np
polymeras
cofactor
gp
transcript
activ
rnadepend
rna
polymeras
l
order
control
evd
ebov
transmiss
effort
made
scientist
identifi
effect
vaccin
two
adenoviru
vaccin
recombin
vesicular
stomat
viru
vaccin
evalu
phase
clinic
trial
expand
phase
number
evd
patient
declin
screen
librari
small
molecul
novel
benzylpiperazin
adamantan
diamid
target
endosom
membran
protein
identifi
inhibit
ebov
infect
cell
confirm
receptor
ebov
carett
et
al
found
receptor
ebov
also
uncov
host
factor
involv
filovirus
entri
process
younan
kondratowicz
reveal
tcell
immunoglobulin
mucin
domaincontain
protein
interact
virionassoci
phosphatidylserin
promot
ebov
infect
act
anoth
receptor
factor
could
consid
potenti
gene
edit
target
ebov
treatment
sever
acut
respiratori
syndrom
sar
spread
rapidli
world
new
coronaviru
sarscov
identifi
diseas
pathogen
harbor
larg
genom
rna
larg
orf
encod
viral
replicasetranscriptas
structur
viru
specif
accessori
protein
year
li
et
al
found
angiotensinconvert
enzym
function
receptor
sarscov
cell
proof
function
vivo
confirm
two
group
huang
et
al
indic
interferoninduc
transmembran
protein
ifitm
also
play
restrict
role
filovirus
sarscov
influenza
viru
entri
thu
provid
altern
target
gene
edit
outbreak
middl
east
respiratori
syndrom
coronaviru
merscov
unlik
sarscov
use
also
name
dipeptidyl
peptidas
receptor
bind
merscov
spike
mediat
membran
fusion
host
protein
tetraspanin
found
form
complex
earli
effici
merscov
entri
host
factor
identifi
use
genom
librari
screen
crispr
offer
altern
gene
target
reemerg
virus
geminiviru
circular
singlestrand
dna
ssdna
viru
seriou
threat
plant
includ
veget
crop
fruit
rnabas
interfer
strategi
use
achiev
geminiviru
resist
transgen
approach
limit
includ
doubl
strand
rna
induc
sequencespecif
dna
methyl
incomplet
elimin
viru
larg
famili
geminivirida
control
infect
geminiviru
becom
ineffici
expens
howev
recent
year
crisprca
system
mediat
viru
resist
use
human
also
plant
directli
edit
viral
gene
disrupt
host
factor
requir
viru
replic
geminivirus
could
effect
resist
plant
balt
colleagu
use
system
transgen
nicotiana
benthamiana
plant
target
replic
initi
protein
gene
bean
yellow
dwarf
viru
beydv
introduc
viru
resist
ji
et
al
show
system
could
perform
high
viral
resist
n
benthamiana
geminiviru
beet
sever
curli
top
viru
bsctv
also
adjust
grna
express
level
viru
suppress
demonstr
higher
express
level
result
obviou
viral
symptom
ali
et
al
also
program
system
target
viral
rep
coat
protein
encod
gene
conserv
intergen
region
ir
n
benthamiana
plant
tomato
yellow
leaf
curl
viru
tylcv
beet
curli
top
viru
bctv
merremia
mosaic
viru
memv
viru
resist
group
also
target
conserv
ir
region
n
benthamiana
plant
result
broad
spectrum
high
viru
interfer
multipl
virus
without
viral
variant
escap
thu
strategi
provid
feasibl
method
broad
durabl
resist
n
benthamiana
plant
variou
virus
escap
host
immun
monitor
frequent
genom
mutat
replic
effici
use
one
grna
target
viru
genom
addit
viru
evolv
util
altern
host
receptor
enter
cell
lead
consider
target
one
host
gene
time
use
facil
versatil
technolog
platform
order
address
issu
multipl
sgrna
combin
target
viral
genom
host
factor
nowaday
possibl
isol
dna
determin
viral
sequenc
individu
patient
one
day
may
lead
design
person
sgrna
induc
crisprca
system
target
sequenc
viral
genom
quickli
easili
effici
data
avail
concern
mammalian
immun
system
respond
crisprca
apparatu
whether
variou
effect
protein
induc
crossreact
antibodi
cell
respons
unknown
crisprca
regul
host
cell
identifi
factor
crisprca
system
repres
power
tool
genom
engin
antiviru
gene
therapi
howev
potenti
offtarget
cleavag
alway
seriou
hurdl
futur
clinic
applic
order
select
highli
specif
effici
sgrna
align
target
sequenc
human
genom
search
potenti
offtarget
site
use
onlin
tool
experiment
confirm
offtarget
effect
alway
fundament
prerequisit
therapeut
treatment
sometim
whole
genom
sequenc
need
applic
patient
specif
target
everi
sgrna
effect
induc
crisprca
cleavag
activ
consequ
one
choos
sgrna
highest
efficaci
lowest
target
effect
knockout
gene
host
cell
crisprca
system
lack
target
gene
affect
normal
physiolog
function
cell
concern
forc
express
endogen
gene
restrict
viru
replic
overload
protein
induc
cytotox
effect
cell
term
prove
altern
target
host
factor
must
identifi
import
regul
viru
lifecycl
crisprca
system
larg
cassett
dnaprotein
complex
safeti
effici
deliv
reagent
anoth
technic
concern
best
method
deliveri
transient
express
ca
protein
grna
ca
mrna
grna
cell
howev
method
often
reli
highli
technic
electropor
machin
larg
quantiti
primari
cell
due
high
voltag
induc
cell
death
addit
vitro
express
ca
protein
transcript
grna
synthesi
grna
cost
labor
work
money
base
previou
report
deliveri
vector
crisprca
contain
adenovir
av
lentivir
lv
adeno
associatedvir
aav
plasmid
av
suitabl
kind
crisprca
system
larg
incorpor
capac
extra
dna
fragment
easi
employ
variou
engin
packag
cell
gener
recombin
av
howev
financi
cost
labor
intens
method
make
difficult
gener
recombin
av
vector
moreov
signific
immunogen
effect
clinic
usag
address
engin
second
third
gener
av
vector
hand
lentivir
vector
mediat
crisprca
deliveri
wide
use
gene
target
divid
nondivid
cell
howev
still
high
risk
induct
tumorigenesi
due
integr
host
genom
integrasedefect
lentiviru
could
valuabl
choic
transient
express
case
aav
packag
size
less
kb
singlestrand
dna
leav
littl
space
insert
genet
element
infus
packag
aav
genom
togeth
sgrna
gene
express
cassett
aavmedi
shown
excis
integr
genom
vivo
use
aav
gene
therapi
vector
mani
advantag
low
toxic
sustain
gene
express
safe
effici
deliveri
report
transduc
primari
cell
hematopoiet
cell
addit
use
deliv
modifi
diseasecaus
mutat
mous
model
duchenn
muscular
dystrophi
suggest
vivo
potenti
deliveri
aav
crystal
structur
ca
explor
subdomain
ca
could
assembl
separ
aav
reconstitut
cell
order
deliv
crisprca
system
function
specif
cell
organ
one
choos
suitabl
induc
promot
regul
casgrna
express
target
cell
organ
decad
ago
berlin
patient
acut
myeloid
leukemia
aml
infect
accept
bonemarrow
transplant
natur
mutat
donor
leukemia
therapi
also
block
infect
without
art
case
open
new
era
cellbas
gene
therapi
lead
sever
clinic
trial
hivinfect
individu
use
zfnmodifi
autolog
cell
hspc
howev
crisprca
base
clinic
test
treatment
aid
viru
relat
diseas
need
evalu
sinc
crisprca
system
emerg
new
gene
edit
technolog
variou
ca
analogu
develop
plausibl
compar
advantag
drawback
everi
method
select
suitabl
one
translat
bench
bedsid
time
research
also
tri
find
host
factor
involv
viru
life
cycl
offer
target
crisprca
edit
crisprca
base
target
host
gene
repres
altern
solut
viru
relat
diseas
treatment
futur
applic
weatherley
et
al
predict
mediat
ex
vivo
gene
edit
hematopoiet
stem
cell
hsc
cure
hiv
antivir
strategi
gene
therapi
show
mani
promis
clinic
result
howev
financi
invest
research
effort
must
made
enhanc
technolog
discoveri
addit
new
crisprca
system
improv
newli
identifi
system
yield
high
gene
edit
effici
low
target
cleavag
explor
mechan
viru
escap
long
term
crisprca
edit
cell
demonstr
host
immun
respons
variou
crisprca
system
regul
involv
dna
target
process
target
screen
relat
test
method
develop
viru
life
cycl
depend
host
target
select
side
effect
gene
knock
inout
activ
develop
new
crisprca
deliveri
vehicl
assembl
function
cassett
preclin
test
viru
infect
anim
model
